A novel lncRNA-mRNA-miRNA signature predicts recurrence and disease-free survival in cervical cancer
Braz. j. med. biol. res; 54 (11), 2021
Cervical cancer (CC) patients have a poor prognosis due to the high recurrence rate. However, there are still no effective molecular signatures to predict the recurrence and survival rates for CC patients. Here, we aimed to identify a novel signature based on three types of RNAs [messenger RNA (mRNAs), m...